Condition
Aortic Intramural Hematoma
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Unknown1
Not Yet Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07272655Not ApplicableNot Yet RecruitingPrimary
AAR/AAR+HAR vs AAR+TAR+FET for Type A Aortic Intramural Hematoma
NCT05996354Not ApplicableUnknown
Concave Supra-arch Branched Stent-Graft System for Treatment of Aortic Arch Diseases
NCT03424785CompletedPrimary
Long Term Clinical Implications in Chinese Patients With Aortic Intramural Hematoma
Showing all 3 trials